SAN FRANCISCO, CA, August 1, 2025 – Arine, the leading AI-powered medication intelligence platform, has been named a 2025 Technology Pioneer by the World Economic Forum (WEF). Arine is one of only a handful of digital health companies selected globally. The annual award honors 100 early-stage companies from around the world that are driving cutting-edge innovation and shaping the future of their industries.
Now in its 25th year, the Technology Pioneers program has recognized industry-defining companies such as Google, Twitter, Airbnb, and Spotify. Arine’s selection affirms the company’s position at the forefront of health tech innovation.
“We’re truly honored to be named a Technology Pioneer by the World Economic Forum,” said Dr. Yoona Kim, PharmD, PhD, co-founder and CEO of Arine. “At a time when healthcare systems around the world are facing greater strain, Arine is proving that data-driven, personalized medication management can dramatically improve outcomes and lower costs – especially for vulnerable populations. This recognition validates the urgency of our mission and the scale of our impact.”
In the U.S. alone, medication-related problems account for around $528 billion in avoidable costs each year and contribute to more than 275,000 preventable deaths. These challenges disproportionately affect underserved communities, where fragmented care and complex conditions increase the risk of medication errors and non-adherence.
Arine’s platform addresses this challenge head-on by integrating diverse data sources – clinical, behavioral, socioeconomic, and pharmacy – to optimize each patient’s medication therapy in real-time. Arine leverages AI and clinical expertise to recommend the right intervention at the right time and continuously learns to improve health at the population level.
To date, Arine’s clients have achieved:
These outcomes have fueled rapid growth, with Arine expanding its reach among more than 45 health plans and risk-bearing providers.
As a newly named Technology Pioneer, Arine will participate in the World Economic Forum’s two-year engagement program, contributing to global discussions on the future of healthcare, artificial intelligence, and equitable innovation. This includes participation in initiatives such as the Centre for the Fourth Industrial Revolution (C4IR), the AI Governance Alliance, and global value-based care working groups.
Arine is the leading AI-powered medication optimization platform that improves patient outcomes and reduces healthcare costs by ensuring that patients receive the most effective and appropriate medications. By integrating advanced analytics with deep clinical expertise, Arine provides timely, personalized recommendations, enabling health plans and risk-based provider organizations to enhance medication safety, adherence, and effectiveness among their members. Learn more at arine.io.
The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation. The Forum engages the foremost political, business, and other leaders of society to shape global, regional, and industry agendas (www.weforum.org).